143 related articles for article (PubMed ID: 36883475)
1. The next generation virus-like particle platform for the treatment of peanut allergy.
Sobczak JM; Krenger PS; Storni F; Mohsen MO; Balke I; Reseviča G; Heath MD; Carreno Velazquez TL; Kramer MF; Scott CJW; Skinner MA; Zeltiņš A; Kündig TM; Vogel M; Bachmann MF
Allergy; 2023 Jul; 78(7):1980-1996. PubMed ID: 36883475
[TBL] [Abstract][Full Text] [Related]
2. Vaccine against peanut allergy based on engineered virus-like particles displaying single major peanut allergens.
Storni F; Zeltins A; Balke I; Heath MD; Kramer MF; Skinner MA; Zha L; Roesti E; Engeroff P; Muri L; von Werdt D; Gruber T; Cragg M; Mlynarczyk M; Kündig TM; Vogel M; Bachmann MF
J Allergy Clin Immunol; 2020 Apr; 145(4):1240-1253.e3. PubMed ID: 31866435
[TBL] [Abstract][Full Text] [Related]
3. Influence of antigen density and TLR ligands on preclinical efficacy of a VLP-based vaccine against peanut allergy.
Krenger PS; Josi R; Sobczak J; Velazquez TLC; Balke I; Skinner MA; Kramer MF; Scott CJW; Hewings S; Heath MD; Zeltins A; Bachmann MF
Allergy; 2024 Jan; 79(1):184-199. PubMed ID: 37815010
[TBL] [Abstract][Full Text] [Related]
4. Targeting Ara h 2 with human-derived monoclonal antibodies prevents peanut-induced anaphylaxis in mice.
Paolucci M; Wuillemin N; Homère V; Bieli D; Köhli A; Ballmer-Weber B; Waeckerle-Men Y; Pengo N; Kündig TM; Sonati T; Johansen P
Allergy; 2023 Jun; 78(6):1605-1614. PubMed ID: 36704937
[TBL] [Abstract][Full Text] [Related]
5. Blockade of peanut allergy with a novel Ara h 2-Fcγ fusion protein in mice.
Liu Y; Sun Y; Chang LJ; Li N; Li H; Yu Y; Bryce PJ; Grammer LC; Schleimer RP; Zhu D
J Allergy Clin Immunol; 2013 Jan; 131(1):213-21.e1-5. PubMed ID: 23199607
[TBL] [Abstract][Full Text] [Related]
6. Strain matters in mouse models of peanut-allergic anaphylaxis: Systemic IgE-dependent and Ara h 2-dominant sensitization in C3H mice.
Paolucci M; Homère V; Waeckerle-Men Y; Wuillemin N; Bieli D; Pengo N; Sonati T; Kündig TM; Johansen P
Clin Exp Allergy; 2023 May; 53(5):550-560. PubMed ID: 36629248
[TBL] [Abstract][Full Text] [Related]
7. A Single Monoclonal Antibody against the Peanut Allergen Ara h 2 Protects against Systemic and Local Peanut Allergy.
Storni F; Cabral-Miranda G; Roesti E; Zha L; Engeroff P; Zeltins A; Cragg M; Vogel M; Bachmann MF
Int Arch Allergy Immunol; 2020; 181(5):334-341. PubMed ID: 32155619
[TBL] [Abstract][Full Text] [Related]
8. A murine model of peanut anaphylaxis: T- and B-cell responses to a major peanut allergen mimic human responses.
Li XM; Serebrisky D; Lee SY; Huang CK; Bardina L; Schofield BH; Stanley JS; Burks AW; Bannon GA; Sampson HA
J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):150-8. PubMed ID: 10887318
[TBL] [Abstract][Full Text] [Related]
9. The 2S albumin allergens of Arachis hypogaea, Ara h 2 and Ara h 6, are the major elicitors of anaphylaxis and can effectively desensitize peanut-allergic mice.
Kulis M; Chen X; Lew J; Wang Q; Patel OP; Zhuang Y; Murray KS; Duncan MW; Porterfield HS; W Burks A; Dreskin SC
Clin Exp Allergy; 2012 Feb; 42(2):326-36. PubMed ID: 22288514
[TBL] [Abstract][Full Text] [Related]
10. IgE recognition patterns in peanut allergy are age dependent: perspectives of the EuroPrevall study.
Ballmer-Weber BK; Lidholm J; Fernández-Rivas M; Seneviratne S; Hanschmann KM; Vogel L; Bures P; Fritsche P; Summers C; Knulst AC; Le TM; Reig I; Papadopoulos NG; Sinaniotis A; Belohlavkova S; Popov T; Kralimarkova T; de Blay F; Purohit A; Clausen M; Jedrzejczak-Czechowcz M; Kowalski ML; Asero R; Dubakiene R; Barreales L; Clare Mills EN; van Ree R; Vieths S
Allergy; 2015 Apr; 70(4):391-407. PubMed ID: 25620497
[TBL] [Abstract][Full Text] [Related]
11. Peanut allergen inhibition prevents anaphylaxis in a humanized mouse model.
Alakhras NS; Shin J; Smith SA; Sinn AL; Zhang W; Hwang G; Sjoerdsma J; Bromley EK; Pollok KE; Bilgicer B; Kaplan MH
Sci Transl Med; 2023 Feb; 15(682):eadd6373. PubMed ID: 36753563
[TBL] [Abstract][Full Text] [Related]
12. An unfolded variant of the major peanut allergen Ara h 2 with decreased anaphylactic potential.
Starkl P; Felix F; Krishnamurthy D; Stremnitzer C; Roth-Walter F; Prickett SR; Voskamp AL; Willensdorfer A; Szalai K; Weichselbaumer M; O'Hehir RE; Jensen-Jarolim E
Clin Exp Allergy; 2012 Dec; 42(12):1801-12. PubMed ID: 23181796
[TBL] [Abstract][Full Text] [Related]
13. Targeting CD22 on memory B cells to induce tolerance to peanut allergens.
Hardy LC; Smeekens JM; Raghuwanshi D; Sarkar S; Daskhan GC; Rogers S; Nycholat C; Maleki S; Burks AW; Paulson JC; Macauley MS; Kulis MD
J Allergy Clin Immunol; 2022 Dec; 150(6):1476-1485.e4. PubMed ID: 35839842
[TBL] [Abstract][Full Text] [Related]
14. Food Allergy Herbal Formula-2 silences peanut-induced anaphylaxis for a prolonged posttreatment period via IFN-gamma-producing CD8+ T cells.
Srivastava KD; Qu C; Zhang T; Goldfarb J; Sampson HA; Li XM
J Allergy Clin Immunol; 2009 Feb; 123(2):443-51. PubMed ID: 19203662
[TBL] [Abstract][Full Text] [Related]
15. Genetic diversity between mouse strains allows identification of the CC027/GeniUnc strain as an orally reactive model of peanut allergy.
Orgel K; Smeekens JM; Ye P; Fotsch L; Guo R; Miller DR; Pardo-Manuel de Villena F; Burks AW; Ferris MT; Kulis MD
J Allergy Clin Immunol; 2019 Mar; 143(3):1027-1037.e7. PubMed ID: 30342892
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy using algal-produced Ara h 1 core domain suppresses peanut allergy in mice.
Gregory JA; Shepley-McTaggart A; Umpierrez M; Hurlburt BK; Maleki SJ; Sampson HA; Mayfield SP; Berin MC
Plant Biotechnol J; 2016 Jul; 14(7):1541-50. PubMed ID: 26801740
[TBL] [Abstract][Full Text] [Related]
17. Type B CpG oligodeoxynucleotides induce Th1 responses to peanut antigens: modulation of sensitization and utility in a truncated immunotherapy regimen in mice.
Kulis M; Gorentla B; Burks AW; Zhong XP
Mol Nutr Food Res; 2013 May; 57(5):906-15. PubMed ID: 23386314
[TBL] [Abstract][Full Text] [Related]
18. Peanut oleosins associated with severe peanut allergy-importance of lipophilic allergens for comprehensive allergy diagnostics.
Schwager C; Kull S; Behrends J; Röckendorf N; Schocker F; Frey A; Homann A; Becker WM; Jappe U
J Allergy Clin Immunol; 2017 Nov; 140(5):1331-1338.e8. PubMed ID: 28342912
[TBL] [Abstract][Full Text] [Related]
19. Ara h 2 and Ara 6 are the best predictors of severe peanut allergy: a double-blind placebo-controlled study.
Kukkonen AK; Pelkonen AS; Mäkinen-Kiljunen S; Voutilainen H; Mäkelä MJ
Allergy; 2015 Oct; 70(10):1239-45. PubMed ID: 26095653
[TBL] [Abstract][Full Text] [Related]
20. Lactobacillus buchneri S-layer as carrier for an Ara h 2-derived peptide for peanut allergen-specific immunotherapy.
Anzengruber J; Bublin M; Bönisch E; Janesch B; Tscheppe A; Braun ML; Varga EM; Hafner C; Breiteneder H; Schäffer C
Mol Immunol; 2017 May; 85():81-88. PubMed ID: 28212503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
